OVERSEA CHINESE BANKING Corp Ltd Purchases Shares of 1,445 The Clorox Company (NYSE:CLX)

OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in The Clorox Company (NYSE:CLX) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 1,445 shares of the company’s stock, valued at approximately $234,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Innealta Capital LLC purchased a new stake in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the last quarter. First Foundation Advisors acquired a new position in shares of Clorox during the 1st quarter worth about $31,000. Family Firm Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at about $31,000. Finally, Quarry LP raised its position in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CLX shares. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson raised their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lifted their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $155.00.

Clorox Trading Up 0.2 %

NYSE:CLX opened at $165.74 on Friday. The stock has a market capitalization of $20.52 billion, a price-to-earnings ratio of 57.75, a PEG ratio of 3.04 and a beta of 0.41. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09. The stock has a fifty day moving average price of $162.38 and a two-hundred day moving average price of $147.21. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the business earned $0.49 earnings per share. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.94%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is currently 170.04%.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.